The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center.

Rachel Su Jen Wong,Jiaxuan Wu,Alisha Joan Leen,Glenn Jin Chong Tey,Yugarajah Asokumaran,Gloria Chan,Chidambaram Siddappan,Anand D. Jeyasekharan,Cheng Ean Chee,Wei Peng Yong,Kee Yuan Ngiam,Raghav Sundar

The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center.

2020

Rachel Su Jen Wong
Jiaxuan Wu
Alisha Joan Leen
Glenn Jin Chong Tey
Yugarajah Asokumaran
Gloria Chan
Chidambaram Siddappan
Anand D. Jeyasekharan
Cheng Ean Chee
Wei Peng Yong
Kee Yuan Ngiam
Raghav Sundar

e16623Background: The management of aHCC has evolved dramatically in recent years, with new agents like immunotherapy receiving regulatory approval. As we begin incorporating these drugs into routi...

Keywords:

Physical therapy
Oncology
real world data
Internal medicine
Hepatocellular carcinoma
Immunotherapy
Targeted therapy
Analytics
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations